As somebody else pointed out we are absolutely looking for improved financial results and of course the Peer Review from the clinical trials. Any of these low low prices is just a gift because as soon as CELZ moves even further upwards we'd all wished we had a larger piece of the pie. One big delicious pie.mmmm